Skip to main content

Table 1 Socio-demographic and disease characteristics of the study population by disease group (N = 300)

From: Immune-mediated inflammatory diseases and nutrition: results from an online survey on patients’ practices and perceptions

Variable Rheumatic diseases Gastrointestinal diseases Psoriasis (N = 50) Overall (N = 300)
RA (N = 50) AS (N = 50) PsA (N = 50) CD (N = 50) UC (N = 50)
Sociodemographic variables
 Age, years
  Mean (95%CI) 50.3 (47.0–53.6) 45.7 (42.7–48.7) 50.4 (47.4–53.4) 44.7 (41.4–48.0) 47.0 (42.9–51.1) 50.8 (46.5–55.0) 48.1 (46.7–49.6)
 Age groups, N (%)
  18–30 years 3 (6) 4 (8) 2 (4) 6 (12) 6 (12) 4 (8) 25 (8)
  31–40 years 8 (16) 13 (26) 7 (14) 12 (24) 12 (24) 12 (24) 64 (21)
  41–50 years 13 (26) 14 (28) 17 (34) 17 (34) 10 (20) 11 (22) 82 (28)
  51–60 years 17 (34) 15 (30) 15 (30) 9 (18) 14 (28) 8 (16) 78 (26)
  61–70 years 8 (16) 3 (6) 8 (16) 6 (12) 5 (10) 9 (18) 39 (13)
   > 70 years 1 (2) 1 (2) 1 (2) 0 (0) 3 (6) 6 (12) 12 (4)
 Gender, N (%)
  Female 45 (90) 44 (88) 41 (82) 41 (82) 29 (58) 34 (68) 234 (78)
 Socio-professional category, N (%)
  Employee 28 (56) 23 (46) 24 (48) 29 (58) 18 (36) 21 (42) 143 (55)
  Executive and senior intellectual profession 12 (24) 14 (28) 7 (14) 8 (16) 11 (22) 16 (32) 68 (26)
  Intermediate profession 1 (2) 4 (8) 5 (10) 3 (6) 4 (8) 1 (2) 18 (7)
  Craftsman, trader, company manager 3 (6) 4 (8) 3 (6) 1 (2) 4 (8) 3 (6) 18 (7)
  Worker 1 (2) 0 (0) 2 (4) 3 (6) 4 (8) 4 (8) 14 (5)
  Not specified 5 (10) 5 (10) 9 (18) 6 (12) 9 (18) 5 (10) 39 (13)
 Body Mass Index, N (%)
  Underweight (<  18.5 kg/m2) 4 (8) 4 (8) 2 (4) 5 (10) 4 (8) 3 (6) 22 (7)
  Normal weight (18.5 and 25 kg/m2) 16 (32) 27 (54) 14 (28) 26 (52) 29 (58) 20 (40) 132 (44)
  Overweight (25 and 30 kg/m2) 16 (32) 14 (28) 17 (34) 13 (26) 12 (24) 10 (20) 82 (28)
  Obese (>  30 kg/m2) 14 (28) 5 (10) 14 (28) 6 (12) 5 (10) 17 (34) 61 (20)
  Inconsistent answer 0 (0) 0 (0) 3 (6) 0 (0) 0 (0) 0 3 (1)
Disease variables
 Disease duration, years
  Mean (95%CI) 8.0 (6.0–10.0) 5.8 (4.2–7.5) 8.0 (4.6–11.4) 15.1 (12.4–17.8) 10.7 (7.7–13.8) 23.5 (19.5–27.4) 11.5 (10.2–12.8)
 Age at diagnosis, years
  Mean (95%CI) 42.4 (39.6–45.3) 39.6 (36.3–43.0) 42.0 (38.3–45.5) 29.6 (26.2–32.9) 36.8 (33.4–40.2) 27.0 (22.0–32.0) 36.5 (34.9–38.1)
 Comorbidities, N (%)
  Another IMID 11 (22) 33 (66) 24 (48) 22 (44) 18 (36) 22 (44) 130 (43)
 HCP, N (%)
  Rheumatologist 47 (94) 47 (94) 46 (92) 5 () 1 (2) 2 (4) 148 (49)
  Gastroenterologist 2 (4) 2 (4) 0 (0) 47 (94) 43 (86) 0 (0) 94 (31)
  General practitioner 15 (30) 19 (38) 8 (16) 6 (12) 11 (22) 12 (24) 71 (24)
  Dermatologist 1 (2) 3 (6) 8 (16) 3 (6) 3 (6) 28 (56) 46 (15)
  Not monitored 1 (2) 1 (2) 0 (0) 2 (4) 6 (12) 11 (22) 21 (7)
 Care facilities, N (%)
  Hospital or clinic only 20 (41) 21 (43) 19 (38) 34 (71) 20 (45) 10 (26) 124 (44)
  Private practice only 12 (24) 7 (14) 22 (44) 4 (8) 11 (25) 22 (56) 78 (28)
  Both private practice and hospital/clinic 17 (35) 21 (43) 9 (18) 10 (21) 13 (30) 7 (18) 77 (28)
 Complications, N (%)
  At least one 39 (78) 44 (88) 42 (84) 48 (96) 41 (82) 38 (76) NA
  Depression 15 (30) 22 (44) 22 (44) 23 (46) 19 (38) 20 (40) NA
  Overweight 20 (40) 13 (26) 20 (40) 16 (32) 9 (18) 13 (26) NA
  Appetite disorders 11 (22) 13 (26) 8 (16) 16 (32) 13 (26) 9 (18) NA
  Articular disorders NC NC NC 28 (56) 13 (26) 19 (38) NA
  Dry eyes/mouth 16 (32) 18 (36) 15 (30) NC NC NC NA
  None 11 (22) 6 (12) 8 (16) 2 (4) 9 (18) 12 (24) NA
Perception of the patients’ level of control of the disease, score
 Mean (95%CI) 5.9 (5.2–6.5) 4.5 (3.8–5.1) 4.2 (3.4–5.0) 6.1 (5.4–6.8) 5.7 (4.9–6.5) 4.8 (4.0–5.5) 5.2 (4.9–5.5)
 Poorly controlled (score < 4), N (%) 9 (18) 18 (36) 21 (42) 11 (22) 13 (26) 20 (40) 92 (31)
 Moderately controlled (score 4–7) 23 (46) 21 (42) 17 (34) 16 (32) 16 (32) 16 (32) 109 (36)
 Well controlled (score ≥ 7) 18 (36) 11 (22) 12 (24) 23 (46) 21 (42) 14 (28) 99 (33)
  1. Abbreviations: NC Not collected, NA Not available, IMID Immune-mediated inflammatory diseases, HCP Healthcare professionals, AS Ankylosing spondylitis, RA Rheumatoid arthritis, PsA Psoriatic arthritis, CD Crohn’s disease, UC Ulcerative colitis